We receive funding from the Duke-Coulter Translational Partnership Program to advance our work on genome editing for Duchenne muscular dystrophy.

June 24, 2014

We receive funding from the Duke-Coulter Translational Partnership Program to advance our work on genome editing for Duchenne muscular dystrophy.